Global Pediatric Neuroblastoma Treatment Market Share

Statistics for the 2023 & 2024 Global Pediatric Neuroblastoma Treatment market share, created by Mordor Intelligence™ Industry Reports. Global Pediatric Neuroblastoma Treatment share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Pharmaceuticals Research Disease Specific Drugs Research Chronic Disorder Drugs Research Oncology Drugs Research Pediatric Neuroblastoma Treatment Industry Market Share

Market Share of Global Pediatric Neuroblastoma Treatment Industry

The pediatric neuroblastoma treatment market is moderately competitive and consists of several major players. Some companies currently dominating the market are United Therapeutics Corporation, APEIRON Biologics AG, Baxter, CELLECTAR BIOSCIENCES, INC, Pfizer, Inc., Bayer AG, MacroGenics, Inc., and Sartorius AG. Product launches, partnerships or collaboration, and continuous investment in research and development are some strategies companies are adopting to enhance their market share.

Pediatric Neuroblastoma Treatment Market Leaders

  1. Baxter International

  2. United Therapeutics Corporation

  3. APEIRON Biologics AG

  4. Y-mAbs Therapeutics, Inc.

  5. CELLECTAR BIOSCIENCES, INC.

*Disclaimer: Major Players sorted in no particular order

Pediatric Neuroblastoma Treatment Market Concentration

Pediatric Neuroblastoma Treatment Market Report Snapshots

Pediatric Neuroblastoma Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)